Follow your heart with Coala
Coala Life develops unique medical innovations that enable long-term monitoring of patients in daily life which can support diagnosis of heart and lungs and improve clinical outcomes.
What is Coala Life?
Enabling online monitoring of heart and lungs
Coala Life is a medical device company founded in Sweden. The company develops unique innovations that enable long-term monitoring and remote diagnostics of heart and lungs. The products offer healthcare providers diagnostic support by the ability to follow patient’s in their everyday life.
Since November 2021, Coala Life is publicly traded on Nasdaq First North Stockholm (Nasdaq: COALA.ST). The head office is based in Uppsala, where research and development also takes place. Manufacturing takes place through partners in Finland and Estonia.
Interim report January – March 2022
May 24, 2022
3 reasons to invest in Coala Life
A growing global market interest
Cardiovascular disease is the leading cause of death today. Coala Life aims to radically improve the quality of life and clinical outcome for the millions of patients affected by cardiovascular disease.
World-leading technology solution
Coala Life’s solutions are based on extensive Swedish research, uniquely accurate algorithms and around 30 patents. The Coala system is CE and FDA approved and is fully reimbursed through the US insurance system.
A team with the right experience
The team behind Coala has experience from global medical technology companies such as Abbott and Boston Scientific. The head office is located in Uppsala, and the company focuses mainly on expansion in the US market through its own sales force.
-
1700 +
doctors and nurses are connected to the Coala Care platform.
-
500 +
healthcare providers are connected to the Coala Care platform with the possibility to follow patients remotely.
-
10000 +
patients in the US and Europe has used, been diagnosed or are under long term monitoring with Coala Heart Monitor.
"We have gained strong market presence and are in line with our targets."
After an eventful quarter, we have progressed further in building what will become a profitable business in the US market.
– Dan Pitulia, President and CEO, Coala Life AB
May 2022
Subscribe
Loading...